Cargando…

Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?

Rupture of HCC (rHCC) is a life-threatening complication of hepatocellular carcinoma (HCC), and rHCC may lead to a high rate of peritoneal dissemination and affect survival negatively. Treatment for rHCC mainly includes emergency surgery, interventional therapies, and palliative treatment. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jingxin, Li, Ting, Deng, Manjun, Fan, Haining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243354/
https://www.ncbi.nlm.nih.gov/pubmed/35785181
http://dx.doi.org/10.3389/fonc.2022.927123
_version_ 1784738288013148160
author Yan, Jingxin
Li, Ting
Deng, Manjun
Fan, Haining
author_facet Yan, Jingxin
Li, Ting
Deng, Manjun
Fan, Haining
author_sort Yan, Jingxin
collection PubMed
description Rupture of HCC (rHCC) is a life-threatening complication of hepatocellular carcinoma (HCC), and rHCC may lead to a high rate of peritoneal dissemination and affect survival negatively. Treatment for rHCC mainly includes emergency surgery, interventional therapies, and palliative treatment. However, the management of rHCC should be carefully evaluated. For patients with severe bleeding, who are not tolerant to open surgery, quick hemostatic methods such as rupture tissue ablation and TAE/TACE can be performed. We described clinical presentation, prognosis, complication, interventional management, and current evidence of rHCC from the perspective of interventional radiologists. Overall, our review summarized that interventional therapies are necessary for most patients with rHCC to achieve hemostasis, even in some patients with Child–Pugh C. Moreover, TAE/TACE followed by staged hepatectomy is a beneficial treatment for rHCC according to current clinical evidence. TAE/TACE is the first choice for most patients with rHCC, and appropriate interventional treatment may provide staged surgery opportunities for those who are not tolerant to emergency surgery to reach an ideal prognosis.
format Online
Article
Text
id pubmed-9243354
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92433542022-07-01 Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know? Yan, Jingxin Li, Ting Deng, Manjun Fan, Haining Front Oncol Oncology Rupture of HCC (rHCC) is a life-threatening complication of hepatocellular carcinoma (HCC), and rHCC may lead to a high rate of peritoneal dissemination and affect survival negatively. Treatment for rHCC mainly includes emergency surgery, interventional therapies, and palliative treatment. However, the management of rHCC should be carefully evaluated. For patients with severe bleeding, who are not tolerant to open surgery, quick hemostatic methods such as rupture tissue ablation and TAE/TACE can be performed. We described clinical presentation, prognosis, complication, interventional management, and current evidence of rHCC from the perspective of interventional radiologists. Overall, our review summarized that interventional therapies are necessary for most patients with rHCC to achieve hemostasis, even in some patients with Child–Pugh C. Moreover, TAE/TACE followed by staged hepatectomy is a beneficial treatment for rHCC according to current clinical evidence. TAE/TACE is the first choice for most patients with rHCC, and appropriate interventional treatment may provide staged surgery opportunities for those who are not tolerant to emergency surgery to reach an ideal prognosis. Frontiers Media S.A. 2022-06-16 /pmc/articles/PMC9243354/ /pubmed/35785181 http://dx.doi.org/10.3389/fonc.2022.927123 Text en Copyright © 2022 Yan, Li, Deng and Fan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yan, Jingxin
Li, Ting
Deng, Manjun
Fan, Haining
Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?
title Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?
title_full Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?
title_fullStr Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?
title_full_unstemmed Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?
title_short Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?
title_sort ruptured hepatocellular carcinoma: what do interventional radiologists need to know?
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243354/
https://www.ncbi.nlm.nih.gov/pubmed/35785181
http://dx.doi.org/10.3389/fonc.2022.927123
work_keys_str_mv AT yanjingxin rupturedhepatocellularcarcinomawhatdointerventionalradiologistsneedtoknow
AT liting rupturedhepatocellularcarcinomawhatdointerventionalradiologistsneedtoknow
AT dengmanjun rupturedhepatocellularcarcinomawhatdointerventionalradiologistsneedtoknow
AT fanhaining rupturedhepatocellularcarcinomawhatdointerventionalradiologistsneedtoknow